Egetis Therapeutics AB (EGTX.ST) Q3 2025 Earnings

21AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.32
-0.27
-0.21
-0.16

Details

Expected EPS
-0.20222806399999999
Actual EPS
-0.2123394672
Surprise EPS
-0.01
Surprise Percent
+5%

Description

Egetis Therapeutics AB (EGTX.ST) has reported earnings of -0.2123394672 per share for Q3 2025.

0 Comments

Share your thoughts